Axonics Inc (NAS:AXNX)
$ 67.22 -0.11 (-0.16%) Market Cap: 3.43 Bil Enterprise Value: 3.13 Bil PE Ratio: 0 PB Ratio: 5.47 GF Score: 83/100

Axonics Modulation Technologies, Inc. - Special Call Transcript

Sep 10, 2020 / NTS GMT
Release Date Price: $37.65 (-1.44%)
Karen Noblett
Axionics Modulation Technologies, Inc. - Chief Medical Officer

Welcome to the Axonics Academy webinar series. My name is Karen Noblett and I am the Chief Medical Officer at Axonics Modulation Technologies and I'm very honored to moderate this webinar this evening. We are very excited for you to join us tonight to hear the first live presentation on the two-year ARTISAN clinical results.

This really represents a landmark study and it provides us the first look at long-term data on a rechargeable sacral neuromodulation system, mostly notably with the Axonics device. The ARTISAN two-year study provides us data on long-term clinical efficacy, patient safety, as well as patient experience. And again, we're very excited to share this data with you tonight.

Now, before we jump into the webinar itself, there's some important safety information that I'd like to share with you. This slide contains standard disclosures on indications, contraindications, precautions with the Axonics system. And if you are interested in learning more about the safety of the Axonics system, we encourage

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot